Hyperion Defi (HYPD) Accumulated Expenses (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Accumulated Expenses of $2.1 million for Q1 2026, up 1783.11% year-over-year from $109934.0 in Q1 2025, and up 10.64% quarter-over-quarter from $1.9 million in Q4 2025.
Hyperion Defi (HYPD) Accumulated Expenses (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Accumulated Expenses for 10 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses rose 1783.11% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 1783.11% YoY), while the FY2025 annual figure was $1.9 million, up 41.46% from the prior year.
- Accumulated Expenses climbed to $2.1 million in Q1 2026 per HYPD's latest filing, from $1.9 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.5 million in Q3 2024 and bottomed at $109934.0 in Q1 2025.
- Historically, Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2025 — Accumulated Expenses slumped 86.73% — and 2026, when it surged 1783.11%.
- Hyperion Defi's Accumulated Expenses stood at $1.7 million in 2022, then dropped by 25.42% to $1.3 million in 2023, then gained by 1.51% to $1.3 million in 2024, then surged by 41.46% to $1.9 million in 2025, then advanced by 10.64% to $2.1 million in 2026.
- Business Quant data shows HYPD's Accumulated Expenses at $2.1 million in Q1 2026, $1.9 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.07 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 109,934.00 |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 828,286.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 295,703.00 |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 460,143.00 |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 675,394.00 |
| Dec 31, 2021 | 845,719.00 |
| Sep 30, 2021 | 1.18 Mn |